PKL-IN-1 is a potent inhibitor of pyruvate kinase ( PKL ) with an IC 50 of 0.07 μM. PKL-IN-1 can be used in the study of non-alcoholic fatty liver disease.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Pyruvate Kinase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.